Sander Kelderman
Impact in
- Oncology top 1%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- Immunology top 2%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
Papers in
- Oncology 12
- Cancer Immunotherapy and Biomarkers 10
- CAR-T cell therapy research 10
- Immunology 10
- Immunotherapy and Immune Responses 8
- Immune Cell Function and Interaction 2
- Co-authors
- Ton N. Schumacher (10 shared papers)John B.A.G. Haanen (6 shared papers)Nienke van Rooij (4 shared papers)Lorenzo F. Fanchi (4 shared papers)Pia Kvistborg (5 shared papers)Krijn K. Dijkstra (2 shared papers)Emile E. Voest (2 shared papers)Carsten Linnemann (2 shared papers)
- Journals
- Science (2 papers)Journal of Clinical Oncology (1 paper)Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (1 paper)Respiratory Medicine (1 paper)Cancer Research (1 paper)
- Partner nations
- NetherlandsSwitzerlandUnited Kingdom
In The Last Decade
Sander Kelderman
15 papers receiving 2.3k citations
Sander Kelderman's Hit Papers
Peers
Comparison fields: 5 of 81
- Oncology 1.5k
- Immunology 1.2k
- Cancer Research 154
- Molecular Biology 542
- Biomedical Engineering 291
Countries citing papers authored by Sander Kelderman
This map shows the geographic impact of Sander Kelderman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sander Kelderman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sander Kelderman more than expected).
Fields of papers citing papers by Sander Kelderman
This network shows the impact of papers produced by Sander Kelderman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sander Kelderman. The network helps show where Sander Kelderman may publish in the future.
Co-authors
The 25 scholars most cited alongside Sander Kelderman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers Hit paper breakdown → | 2018 | 382 |
| 2 | 2016 | 326 | |
| 3 | 2014 | 291 | |
| 4 | 2019 | 269 | |
| 5 | 2012 | 267 | |
| 6 | 2014 | 242 | |
| 7 | 2014 | 229 | |
| 8 | 2014 | 145 | |
| 9 | 2015 | 65 | |
| 10 | 2016 | 31 | |
| 11 | 2015 | 20 | |
| 12 | 2015 | 9 | |
| 13 | 2013 | 2 | |
| 14 | 2013 | 2 | |
| 15 | [Sternoclavicular joint tuberculosis]. | 2012 | 1 |
| 16 | 2025 | 0 |
About Sander Kelderman
Sander Kelderman is a scholar working on Oncology, Immunology, Epidemiology, Surgery and Molecular Biology, having authored 16 papers that have together received 2.3k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (10 papers), CAR-T cell therapy research (10 papers), Immunotherapy and Immune Responses (8 papers), Immune Cell Function and Interaction (2 papers), Cancer Genomics and Diagnostics (1 paper), Shoulder and Clavicle Injuries (1 paper), Mycobacterium research and diagnosis (1 paper) and Inhalation and Respiratory Drug Delivery (1 paper). The work is most often cited by research in Oncology (1.5k citations), Immunology (1.2k citations), Cancer Research (154 citations), Molecular Biology (542 citations) and Biomedical Engineering (291 citations). Sander Kelderman has collaborated with scholars based in Netherlands, Switzerland and United Kingdom. Frequent co-authors include Ton N. Schumacher, John B.A.G. Haanen, Nienke van Rooij, Lorenzo F. Fanchi, Pia Kvistborg, Krijn K. Dijkstra, Emile E. Voest, Carsten Linnemann, Marit M. van Buuren and Mireille Toebes. Their work appears in journals such as Science, Journal of Clinical Oncology, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, Respiratory Medicine and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.